Condition: Rhegmatogenous Retinal Detachment - Macula Off · Sponsor: Photofuse Pty Ltd
This study is a first-in-human clinical trial testing a new treatment for rhegmatogenous retinal detachments. The new treatment called retinal thermofusion uses a special laser device called iSeelr™ during surgery. The benefit of the device is that it repairs retinal tears without needing a gas bubble making it quicker to recover from surgery. The study will help us determine how safe and well the device performs in repairing a retinal detachment in people.
This description comes directly from the study's public registry record.
Peter Keller · +61 3 9929 8348 · peter.keller@eyeandear.org.au
Always discuss trial participation with your own doctor first.
| The Royal Victorian Eye and Ear Hospital (RVEEH) | East Melbourne, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06468397